FindTrial
Sign In

Comparison of Quality of Recovery - 15 score (QOR-15) in patients undergoing breast surgery for cancer following nerve block for pain control with two different drugs

Comparison of Quality of Recovery - 15 (QOR-15) in patients undergoing breast surgery for cancer following PECS block with Levobupivacaine and Ropivacaine- A Double Blinded, Randomized Controlled Trial - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070630
Enrollment
70
Registered
2024-07-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C50- Malignant neoplasm of breast

Interventions

Intervention1: LEVOBUPIVACAINE: 0.375%, administered in between pectoralis major and minor muscle (PECS I and II) via ultrasound guided, one time after induction of anesthesia. Control Intervention1:

Sponsors

Dr Piyush Garg
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA grade I – III 2. Weight more than 50 kgs 3. Patients scheduled for breast surgery for cancer under general anesthesia

Exclusion criteria

Exclusion criteria: 1. Patients with a history of bleeding disorders or patients on anticoagulation therapy 2. Patients with known allergy/hypersensitivity to local anesthetic drugs/ study drugs 3. Patients with local infections at the site of block 4. Patients who received opioids within the 24-hour period before surgery. 5. Patient refusal to consent for the procedure 6. Patients with significant psychiatric illness, neurological, cardiovascular, and renal diseases. 7. Patients with opioid dependence, chronic alcoholic use, severe obesity

Design outcomes

Primary

MeasureTime frame
?To evaluate the quality of the recovery (QoR-15) score following administration of Ropivacaine (group R) and Levobupivacaine (group L) in PECS block in patients undergoing breast surgeries.Timepoint: Baseline and 24 hours after surgery—

Secondary

MeasureTime frame
? Ease of physiotherapy in the postoperative periodTimepoint: AFTER 24 HOURS OF THE SURGERY; ? To note any adverse effects/complications in both groupsTimepoint: DURING THE DURATION OF THE SURGERY; ? To note the requirement of rescue analgesia i.e. fentanyl in both sets of patientsTimepoint: WITHIN 24 HOURS AFTER SURGERY—

Countries

India

Contacts

Public ContactDr Punit Mehta

Max Super Speciality Hospital

drpunitmehta@gmail.com9818850783

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026